I owned PPHM long before PTSC. I came across the company, years ago, in a medical article discussing future antibodies for cancer. I sold it for a very modest return, never even realizing Swartz was involved. I didn't know anything about him until my purchase of PTSC in early 2006. Carlton Johnson is a busy man. It is quite a circle Swartz and company has created. I admire their ability to turn BOD positions into full time jobs. My hats off to them for creating such an insulated refuge for themselves. I suspect we will see Mr. Johnson's PTSC board fees reduced. Surely he doesn't need the income having now assumed the prominent position of Chairman at PPHM? I look forward to his announcement regarding a voluntary fee reduction from his Patriot position. One would think that is a safe assumption knowing he can't possibly maintain his "working board" status. Thank you Mr. Johnson. Definitely a man of the people.

P.S.---To my former PPHM investors. Should you be fortunate enough to see success with the Cotora drug, look for a heavy dose of dividend distribution followed by utter astonishment when the BOD realizes that licensing of the drug isn't going as planned.